July 03, 2020 01:57 AM Eastern Daylight Time

BUSINESS WIRE

EUSA Pharma宣布FDA核准Silvoximab治疗COVID-19相关急性呼吸窘迫综合征住院患者的3期临床试验

Opens in new window

Download

Full Size JPEG, 1024x219, 23.1 KB
Small JPEG, 480x103, 7.8 KB
Preview JPEG, 144x31, 1.7 KB
Thumbnail JPEG, 120x26, 1.3 KB

Smart Multimedia Gallery

http://www.businesswire.it/multimedia/it/20200702005623/zh-CN/4783830/

Share

Email

All News | News with Multimedia > Press Release: EUSA Pharma宣布FDA核准Silvoximab治疗COVID-19相关急性呼吸窘迫综...